Abstract Search

ea0050p271 | Neuroendocrinology and Pituitary | SFEBES2017

Inpatient prescribed desmopressin nasal spray is omitted three times more often than desmopressin prescribed by other routes

MacFarlane Catherine , Francis Rachel , Amilah Bonita , Billoo Zoya , Cavell Gillian , Chudley James , Fidler Ben , Mustafa Omar , Whitelaw Benjamin

Over the past decade there has been increased recognition of the dangers associated with inpatient management of diabetes insipidus (DI) and omission of desmopressin. An NHS England patient safety alert was issued in 2016 highlighting this risk.Method: Using electronic prescribing records we reviewed all desmopressin prescriptions and omissions over a 12 month period in a large teaching hospital.Results: Ninety-seven inpatients wer...

0 shares

ea0050p271 | Neuroendocrinology and Pituitary | SFEBES2017

Inpatient prescribed desmopressin nasal spray is omitted three times more often than desmopressin prescribed by other routes

MacFarlane Catherine , Francis Rachel , Amilah Bonita , Billoo Zoya , Cavell Gillian , Chudley James , Fidler Ben , Mustafa Omar , Whitelaw Benjamin

0 shares

Endocrine Abstracts

Inpatient prescribed desmopressin nasal spray is omitted three times more often than desmopressin prescribed by other routes

Inpatient prescribed desmopressin nasal spray is omitted three times more often than desmopressin prescribed by other routes

BiosciAbstracts